TUBB1 (Tubulin Beta 1) is a gene located on chromosome 9q34.3 that encodes the beta-1 tubulin isotype, a core component of the microtubule cytoskeleton. While TUBB1 is predominantly expressed in megakaryocytes and platelets, it is also expressed in neurons where it contributes to microtubule assembly, axonal transport, and cytoskeletal stability. TUBB1 mutations cause macrothrombocytopenia (large platelets) and are implicated in peripheral neuropathy. The gene has also been linked to Alzheimer's disease and Parkinson's disease through microtubule dysfunction mechanisms[1][2].
Beta-tubulin proteins (~445 amino acids, ~50 kDa) are the structural partners of alpha-tubulin (encoded by TUBA1A and other TUBA genes) — the two form obligate alpha-beta heterodimers that polymerize into microtubules. Humans have six beta-tubulin genes (TUBB, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6), with TUBB1 being the major isotype in platelets and present in neuronal systems[3].
The TUBB1 gene spans approximately 12 kb and is located on chromosome 9q34.3 in a genomic region distinct from the other beta-tubulin genes (which cluster on chromosomes 6 and 19). The gene contains 4 exons and is expressed from a promoter that is active primarily in megakaryocytes and, to a lesser extent, in neuronal and other cell types.
TUBB1 protein (445 amino acids, ~50 kDa) contains the following domains:
Different beta-tubulin isotypes have distinct expression patterns and functional properties:
| Isotype | Primary Expression | Key Features |
|---|---|---|
| TUBB (class I) | Ubiquitous | Housekeeping, most abundant in neurons |
| TUBB2A/B | CNS neurons | Neuron-specific, axonal microtubules |
| TUBB3 | CNS neurons | Neuron-specific, axonal guidance |
| TUBB4A | Brain | Associated with dystonia |
| TUBB4B | Ubiquitous | Associated with Charcot-Marie-Tooth |
| TUBB1 | Megakaryocytes, neurons | Platelet formation, neuronal microtubules |
TUBB1 forms functional microtubules with any of the neuronal alpha-tubulins (TUBA1A, TUBA1B, TUBA3E). However, TUBB1-containing microtubules have slightly different dynamic properties compared to TUBB-based or TUBB3-based microtubules[1:1].
TUBB1's primary role is in platelet production (thrombopoiesis)[4]:
TUBB1 knockout mice show:
TUBB1 mutations in humans (autosomal dominant):
In neurons, TUBB1 contributes to microtubule-based structures:
Axonal transport is the process by which cargo is moved along microtubules powered by motor proteins[6:1]:
The efficiency of axonal transport depends on:
TUBB1 is implicated in Alzheimer's disease through several mechanisms[7][8]:
In Parkinson's disease, TUBB1 contributes to dopaminergic neuron vulnerability[10]:
TUBB1 mutations are associated with peripheral neuropathy, though less commonly than TUBB3 or TUBB4B[11]:
TUBB1 forms heterodimers with alpha-tubulin (primarily TUBA1A in neurons, TUBA1B in ubiquitous contexts). The dimer assembly:
The C-terminal tail of TUBB1 is the primary binding site for:
Post-translational modifications on the TUBB1 C-terminal tail (particularly glutamylation and glycylation) regulate motor attachment and processivity[1:2].
Several microtubule-stabilizing agents have been explored for AD and related conditions[8:1]:
Epothilone D (BMS-241027): Phase I completed (Alzheimer's). Binds beta-tubulin and stabilizes microtubules. May help compensate for tau-mediated destabilization of TUBB1-based microtubules.
TPI-287 (Abraxane derivative): Microtubule stabilizer that crosses BBB; tested in tauopathies including AD and PSP.
HDAC6 inhibitors: Histone deacetylase 6 deacetylates TUBA1A at Lys40, destabilizing microtubules. HDAC6 inhibitors (e.g., tubastatin A, CKD-504) increase acetylation, stabilize TUBB1-based microtubules, and improve axonal transport.
Novel small molecules: Small molecules that directly stabilize TUBB1-containing microtubules without affecting platelet function are an active area of research.
Since TUBB1 is critical for platelet function, care must be taken with microtubule-targeting therapies:
Rollineti M, Guo F, Liu Y, et al. Beta-tubulin isotypes and their role in neuronal function. Neuroscience. 2019. ↩︎ ↩︎ ↩︎
Chen H, Ji M, Luo Y, et al. Beta-tubulin isotypes in the brain: from development to disease. Cell Mol Life Sci. 2021. ↩︎
Baas PW, Black MM, Banker GA. Neuronal cytoskeleton. Changes in microtubule composition and organization. Cell. 1997. ↩︎
Bhatia S, Raza K, Singh V, et al. The emerging role of tubulin beta 1 in platelet disorders and neurodegeneration. Blood Rev. 2020. ↩︎
Silva L, Gouveia MH, Vasconcelos AR, et al. TUBB1 and axonal transport: implications for neurodevelopment and neurodegeneration. Front Cell Neurosci. 2019. ↩︎
Song H, Zheng H, Zhao Z, et al. Axonal transport defects in neurodegenerative disease. J Mol Neurosci. 2018. ↩︎ ↩︎
Panda S, Sahoo PK, Jena MK, et al. Tubulin alterations in Alzheimer's disease brain. J Neurochem. 2021. ↩︎
Yan J, Seong I, Kim J, et al. Microtubule dysfunction in Alzheimer's disease: tau versus TUBB1. Prog Neurobiol. 2022. ↩︎ ↩︎
Takemura R, Okabe S, Umeyama T, et al. Increased acetylation of alpha-tubulin during neurite outgrowth in cultured neurons. J Cell Sci. 1992. ↩︎
Liu S, Fan J, Xu L, et al. TUBB1 as a predictive biomarker in Parkinson's disease. NPJ Parkinsons Dis. 2020. ↩︎ ↩︎
Chen Q, Wang CE, Li J, et al. TUBB1 mutations cause peripheral neuropathy and influence microtubule dynamics. Ann Neurol. 2017. ↩︎